REDEFINE 4: The Tirzepatide Test The results that attracted the greatest market attention came from REDEFINE 4, an 84-week open-label Phase 3 trial reported in February 2026, in which CagriSema was pitted directly against tirzepatide 15 mg, the highest approved dose of Eli Lillys Zepbound
Supports cellular repair Better blood sugar and body composition translate into cleaner circulation and more efficient nutrient delivery, which skin needs to repair on time
This same mechanism drives weight loss
All tests were negative so they did an abdominal CAT scan which showed paralysis of the small intestines...(paralytic ileus)
According to the prescribing information for Ozempic and Wegovy, users should stop taking Ozempic two months before they plan to conceive to ensure that the semaglutide is out of their system during pregnancy
References Askarpour, M., Hadi, A., Miraghajani, M., Symonds, M., Sheikhi, A., & Ghaedi, E